Ars Technica

Moderna's mRNA flu shot earns FDA approval after rollercoaster review

Moderna's mRNA flu shot earns FDA approval after rollercoaster reviewWorldPing

Moderna's new flu vaccine, mFLUSIVA, is approved for all adults ages 50 and up.

This is a short WorldPing brief. The full report was published by Ars Technica.

Read the full report at Ars Technica

Related news